Need professional-grade analysis? Visit stockanalysis.com
$14.33B
16.37
5,815
N/A
Zhejiang Medicine Co Ltd (600216) trades on SHG in CNY. The company is classified in the Healthcare sector under the Drug Manufacturers - Specialty & Generic industry. The stock currently trades at CNY14.90, down 2.80% from the previous close.
Over the past year, 600216 has traded between a low of CNY13.33 and a high of CNY18.38. The stock has gained 10.3% over this period. It is currently 18.9% below its 52-week high.
Zhejiang Medicine Co Ltd has a market capitalization of $14.33B, with a price-to-earnings ratio of 16.37.
Zhejiang Medicine Co., Ltd. manufactures and sells life nutrition and medical products in China and internationally. The company offers synthetic vitamin E, natural vitamin E, ß-carotene, cantharidin, vancomycin hydrochloride, and teicoplanin. It also provides fat-soluble vitamins, retinoids, quinolone antibiotics, anti-resistance antibiotics, and other products, as well as animal nutrition products. In addition, the company offers injectable levofloxacin lactate, injectable vancomycin hydrochloride injections, and injectable teicoplanin products. The company was incorporated in 1997 and is based in Shaoxing, China.
Side-by-side comparison against top Healthcare peers.